The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences
- 10 January 2002
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 128 (1-3) , 229-241
- https://doi.org/10.1016/s0378-4274(01)00544-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- POLYMORPHISMS OF N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASE MU AND THETA GENES AS RISK FACTORS OF BLADDER CANCER IN RELATION TO ASTHMA AND TUBERCULOSISJournal of Urology, 2000
- Arylaminc N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among JapanesePharmacogenetics, 1999
- N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workersCarcinogenesis: Integrative Cancer Research, 1993
- Acetylation Phenotypes and Bladder CancerJournal of Occupational and Environmental Medicine, 1990
- Screening for Bladder Cancer at the Du Pont Chambers Works: Initial FindingsJournal of Occupational and Environmental Medicine, 1986
- The association of the slow acetylator phenotype with bladder cancer.Journal of Medical Genetics, 1983
- N-Acetylation Phenotype in Bladder CancerHuman Toxicology, 1982
- Role of N-Acetyltransferase Phenotype in Human Susceptibility To Bladder Carcinogenic ArylaminesScandinavian Journal of Urology and Nephrology, 1980
- N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and DenmarkEnvironmental Health Perspectives, 1979
- An improved and simplified method of detecting the acetylator phenotype.Journal of Medical Genetics, 1969